162 related articles for article (PubMed ID: 36557000)
1. Essential Thrombocythemia: One-Center Data in a Changing Disease.
Pirciulescu N; Gaman MA; Mihailescu M; Constantin C; Dragomir M; Dobrea C; Costache S; Ursuleac I; Coriu D; Crisan AM
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557000
[TBL] [Abstract][Full Text] [Related]
2. Comparison between thrombotic risk scores in essential thrombocythemia and survival implications.
Santoro M; Accurso V; Mancuso S; Carlisi M; Raso S; Tarantino G; Di Piazza F; Perez A; Russo A; Siragusa S
Hematol Oncol; 2019 Oct; 37(4):434-437. PubMed ID: 31465530
[TBL] [Abstract][Full Text] [Related]
3. [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients].
Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Garcia-Pallarols F; Longarón R; Ancochea À; Besses C
Med Clin (Barc); 2015 Mar; 144(6):247-53. PubMed ID: 25192581
[TBL] [Abstract][Full Text] [Related]
4. Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.
Haider M; Gangat N; Lasho T; Abou Hussein AK; Elala YC; Hanson C; Tefferi A
Am J Hematol; 2016 Jun; 91(4):390-4. PubMed ID: 26799697
[TBL] [Abstract][Full Text] [Related]
5. Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service.
Navarro LM; Trufelli DC; Bonito DR; Del Giglio A; Bollmann PW
Rev Assoc Med Bras (1992); 2016 Oct; 62(7):647-651. PubMed ID: 27925044
[TBL] [Abstract][Full Text] [Related]
6. Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L; Liberi M; Morelli G; Zannier ME; Lazzarotto D; Filì C; Simeone E; Battaglia G; Callegari C; Fanin M; Damiani D; Fanin R; Tiribelli M
Ann Hematol; 2024 Feb; 103(2):443-448. PubMed ID: 38072850
[TBL] [Abstract][Full Text] [Related]
7. External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.
Fu R; Xuan M; Lv C; Zhang L; Li H; Zhang X; Zhang D; Sun T; Xue F; Liu X; Liang H; Zhang L; Yang R
Eur J Haematol; 2014 Jun; 92(6):502-9. PubMed ID: 24460750
[TBL] [Abstract][Full Text] [Related]
8. Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
Guglielmelli P; Carobbio A; Rumi E; De Stefano V; Mannelli L; Mannelli F; Rotunno G; Coltro G; Betti S; Cavalloni C; Finazzi MC; Thiele J; Cazzola M; Vannucchi AM; Barbui T
Blood Cancer J; 2020 Feb; 10(2):21. PubMed ID: 32098944
[TBL] [Abstract][Full Text] [Related]
9. Is the absence of JAK2 mutation a risk factor for bleeding in essential thrombocythemia? An analysis of 106 patients.
Patriarca A; Pompetti F; Malizia R; Iuliani O; Di Marzio I; Spadano A; Dragani A
Blood Transfus; 2010 Jan; 8(1):21-7. PubMed ID: 20104275
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis.
Yang E; Wang M; Wang Z; Li Y; Wang X; Ming J; Xiao H; Quan R; Liu W; Hu X
Ann Hematol; 2021 Nov; 100(11):2699-2706. PubMed ID: 34383101
[TBL] [Abstract][Full Text] [Related]
11. [Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Iványi JL; Marton E; Plander M
Orv Hetil; 2011 Nov; 152(45):1795-803. PubMed ID: 22011365
[TBL] [Abstract][Full Text] [Related]
12. [Thrombotic events and significance of the IPSET thrombosis risk evaluation score in essential thrombocythaemia].
Pósfai É; Marton I; Nemes A; Borbényi Z
Orv Hetil; 2015 Apr; 156(14):558-63. PubMed ID: 25819149
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic risk correlates with mutational status in true essential thrombocythemia.
Bertozzi I; Peroni E; Coltro G; Bogoni G; Cosi E; Santarossa C; Fabris F; Randi ML
Eur J Clin Invest; 2016 Aug; 46(8):683-9. PubMed ID: 27271054
[TBL] [Abstract][Full Text] [Related]
14. The association of JAK2V617F mutation and leukocytosis with thrombotic events in essential thrombocythemia.
Hsiao HH; Yang MY; Liu YC; Lee CP; Yang WC; Liu TC; Chang CS; Lin SF
Exp Hematol; 2007 Nov; 35(11):1704-7. PubMed ID: 17920754
[TBL] [Abstract][Full Text] [Related]
15. JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.
Pósfai É; Marton I; Király PA; Kotosz B; Kiss-László Z; Széll M; Borbényi Z
Pathol Oncol Res; 2015 Jul; 21(3):751-8. PubMed ID: 25573593
[TBL] [Abstract][Full Text] [Related]
16. The risk of thrombosis in essential thrombocythemia is associated with the type of CALR mutation: A multicentre collaborative study.
Pérez Encinas MM; Sobas M; Gómez-Casares MT; Abuin Blanco A; Noya Pereira MS; Raya JM; Andrade-Campos MM; Álvarez Larrán A; Lewandowski K; Łukasz S; Hernández Boluda JC; Ferrer-Marín F; Fox ML; Gołos A; Gasior Kabat M; Magro Mazo E; Czyż A; Martín Martín A; Bellosillo Paricio B; Quinteiro García C; González Martín JM; Stuckey R
Eur J Haematol; 2021 Mar; 106(3):371-379. PubMed ID: 33275803
[TBL] [Abstract][Full Text] [Related]
17. Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients.
Chim CS; Sim JP; Chan CC; Kho BC; Chan JC; Wong LG; Law M; Liang R; Kwong YL
Hematology; 2010 Aug; 15(4):187-92. PubMed ID: 20670476
[TBL] [Abstract][Full Text] [Related]
18. IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
Sevindik OG; Mersin S; Katgi A; Tunali S; Solmaz SM; Acar C; Alacacioglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e101-4. PubMed ID: 25790738
[TBL] [Abstract][Full Text] [Related]
19. [Clinical evaluation of the revised International Prognostic Score of Thrombosis for essential thrombocythemia (IPSET-thrombosis) in a cohort of 746 Chinese adult patients].
Fu RF; Li HY; Xue F; Liu XF; Liu W; Huang YT; Chen YF; Zhang LY; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):92-96. PubMed ID: 28279030
[No Abstract] [Full Text] [Related]
20. Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia.
Hashimoto Y; Nakamae H; Tanaka T; Omura H; Horiuchi M; Yoshimura T; Takakuwa T; Mugitani A; Hirose A; Nakamae M; Koh H; Hino M
Eur J Haematol; 2018 Oct; 101(4):508-513. PubMed ID: 29971894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
